Table 5. Comparison of the haemodynamic parameters with other studies.
HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; Group R: ropivacaine group
| Study | HR | SBP | DBP | MBP | SpO₂ |
| Present study | Group R lower from 15 min onwards (p<0.05) | Group R lower from 30 min onwards (p<0.05) | Similar except at 6 min (lower in Group R; p=0.007) | Comparable throughout | Stable and comparable |
| Bhalekar et al. [8] | Not explicitly compared | Not detailed | Not detailed | Not mentioned | Not mentioned |
| Hazarika et al. [9] | No significant difference | Significant at 5, 10, and 75 min | Significant at 5, 30, and 180 min | Not reported | Not reported |
| Sharma et al. [10] | Ropivacaine showed a more stable HR | Smaller drop in Group R (more stable) | Less drop in Group R | Higher in Group R (p<0.05) | Stable and comparable |